在老鼠心力衰竭模型中,用于腺相关病毒介导的miRNA输送的协议
Iqra Mushtaq1, Yu-Hsun Kao2, Yi-Jen Chen3
1International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
STAR protocols
|December 13, 2024
概括
这项研究详细介绍了使用腺相关病毒血清型9 (AAV9) 和心力衰竭小鼠的水力动力输血向心脏输送微型RNA (miRNA) 的协议. 该方法使心脏组织中有效的miRNA传递和表达分析成为可能.
科学领域:
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 治疗性microRNAs (miRNAs) 的有效输送到心脏对于治疗心脏病至关重要.
- 当前的方法在有效地准受影响的器官方面面临挑战.
- 基因相关病毒 (AAV) 载体对心脏基因治疗有希望.
研究的目的:
- 在大鼠模型中,向失败的心脏输送miRNA的详细方案.
- 建立一种可靠的方法来评估分娩后心脏组织中的miRNA表达.
主要方法:
- 在老鼠模型中诱导心力衰竭.
- 通过水力动力输血应用腺相关病毒血清型9 (AAV9).
- 心声造影仪用于评估心脏功能.
- 干循环RT-qPCR用于心脏组织中miRNA表达分析.
主要成果:
- 在心力衰竭的老鼠模型中,该协议成功地将miRNA输送到心脏.
- 该方法允许对心脏组织中miRNA表达的定量评估.
- 腺相关病毒血清型9 (AAV9) 与水力动力输血相结合是一种有效的输送策略.
结论:
- 该协议为心脏miRNA输送和评估提供了一个强大的方法.
- 描述的技术可能对基于miRNA的心脏治疗方法的临床前研究有价值.
- 有效的miRNA输送是开发心力衰竭新型治疗方法的关键.
相关概念视频
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...


